Google's Isomorphic Labs Raises Over $2 Billion for AI Drug Discovery

Isomorphic Labs, the AI-powered drug discovery company spun out of Google DeepMind, is in advanced discussions to raise more than $2 billion in new funding. The round marks one of the largest biotech AI funding rounds to date, reflecting growing investor interest in applying artificial intelligence to pharmaceutical development.

Isomorphic Labs funding round

• ▪Isomorphic Labs is in advanced discussions to raise more than $2 billion in a new round of funding

AI drug discovery focus

• ▪Isomorphic Labs is an AI-powered drug discovery company

Google DeepMind spinout

• ▪Isomorphic Labs was spun out of Alphabet Inc.'s Google DeepMind